LONDON (Thomson Financial) - Proteome Sciences Plc. said it has entered into
an exclusive license agreement for its TMT isobaric tandem mass tag technology
with Thermo Fisher Scientific Inc.
The company said it will manufacture its patented TMT reagents exclusively
for Thermo Fisher Scientific, which will market and sell them worldwide through
the Thermo Scientific Pierce product line.
Proteome Sciences said it expects double-digit growth in the market for
isobaric tandem mass tags and will receive signature fees, contract
manufacturing payments and royalties on sales with additional sales milestones
from the license.
"We intend to have TMT products available in the market during the second
quarter of the year, fully supported by our strong sales and marketing
organization," said Ian Jardine, vice president of global research and
development for Thermo Fisher Scientific.
TFN.newsdesk@thomson.com
tsm/am
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|